Atom | Part the Cloud Translational Research for Alzheimer’s Disease Program: Enable the Molecule for Artificial Intelligence-Discovered Programs (PTC-EM-AI) Funding Program

Due Dates: March 26, 2026 (Letter of Intent) | April 30, 2026 (Full application)

Funding Amounts: Up to $1,000,000 total (direct and indirect costs) over up to 3 years; indirect costs capped at 10% for non-profits only.

Summary: Supports translational advancement of AI-discovered drug candidates for Alzheimer’s disease through lead optimization and IND-enabling studies.

Key Information: Projects must originate from AI/ML-driven discovery and focus on disease-modifying therapeutics for Alzheimer’s or related dementias.

Part the Cloud Translational Research for Alzheimer’s Disease Program: Enable the Molecule for Artificial Intelligence-Discovered Programs (PTC-EM-AI) Funding Program

Sign in to see full grant listing